Egypt has a long lead in the treatment of drug-resistant tuberculosis

Dr. Wagdi Amin, director of the General Directorate of Diseases and the National Tuberculosis Program, said Egypt had taken the lead in treating drug-resistant tuberculosis in the eastern Mediterranean region , where the treatment of patients with resistant tuberculosis was launched in 2006 starting with the first section of Abbasid Hospital of 65 beds. Al Mamoura received 40 beds in 2008 and Mansoura in 2012 and plans to create a fourth department serving patients of Assiut Hospital of Upper Egypt, with a capacity of 28 beds, noting that the provision of second row of patients lasts two years as part of the national TB program. They are given to patients free of charge and the cost of treatment up to about $ 4,000 compared to normal treatment, which costs around 600 Egyptian pounds only.

Ameen pointed out that the national tuberculosis program had achieved great achievements in 2018. The intensive care departments were inaugurated in the hospitals of Al Mamoura, Al-Shakafa, Al-Menia and Beni Suef, as well as that the renewal of intensive care unit of Sadr Zaqaziq Hospital, In cooperation with the Egyptian Association of Bronchial Medicine Hospitals Imbaba, Mansoura, Maamoura and Shebin El Koum, this number will be increased to 15 clinics by the end of 2019.

He added "Amin" that a number of hospitals were equipped with devices such as Fayoum, Ismailia, Maamoura and Kok al-Shakafa hospitals where oxygen tanks were used . And began the operation of a gas network in Qena hospital to establish a targeted health center, and was formed in the number of 2035 trainees in various training programs.

The number of people with TB in the world is estimated at 10 million, including 5.8 million in adult men, 3.2 million in adult women and 1 million in children, and 90% of TB cases occur in adults over 18 years of age and 9% of those infected are also infected. And that about 6.4 million new patients were detected by detecting 64% of the expected cases.

82% of cases have been successfully treated, including 54 million between 2000 and 2017. The number of TB deaths has decreased by 47% from the 1990 level. This marked improvement has been better since 2000 and 1.2 million of patients. The number of people infected with AIDS has been estimated at 558 000 patients, particularly for rifampicin, which is the most effective drug treatment for tuberculosis: 82% of them have multidrug-resistant tuberculosis, drug-resistant tuberculosis was 3.6% in new patients and 17% in retreatment patients, of which 160,684 were identified and approximately 139% of HIV cases were treated, or approximately 87%. In addition, 1.7 billion of the world's population is infected with latent tuberculosis, while the tuberculosis death rate has fallen to 16% in 2017..